Website News and Research

RSS

Estimating budget sequestration's impact on global health, foreign aid

Writing in the U.S. Global Leadership Coalition's (USGLC) blog, Molly Lester, government relations associate at the USGLC, highlights a report released last week by the House Appropriations Committee Democrats that outlines the potential impact of budget sequestration on different agencies and issues.

20 Feb 2013

MIR names Aetna as Health Insurer of the Year

Aetna a leading global diversified health care benefits company, has been named "Health Insurer of the Year" for 2013 by MENA Insurance Review (MIR), a leading magazine covering the insurance sector in the Middle East and North Africa.

18 Feb 2013

U.N. officials mark campaign against violence against women

U.N. officials on Thursday "joined millions of people around the world who are taking a stance against violence against women as part of the One Billion Rising campaign," the U.N. News Centre reports.

16 Feb 2013

U.N. joint meeting addresses issues surrounding food security

"Scaling up the global response to food security and nutrition topped the agenda [Thursday] at a special joint meeting between the United Nations Economic and Social Council (ECOSOC), the General Assembly, world experts and the U.N. food agencies aimed at identifying steps to build a future free of hunger," the U.N. News Centre reports, noting the meeting "included the Food and Agriculture Organization (FAO), the International Fund for Agricultural Development (IFAD) and the World Food Programme (WFP)."

16 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Nucleic Acid Therapeutics publishes special research section on noncoding RNAs

As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention. Guest Editor Tom Cech, PhD and Executive Editor Fintan Steele, PhD explore the enormous potential value of this rapidly advancing research area in their Editorial " The (Noncoding) RNA World."

15 Feb 2013

Castle Biosciences launches MyUvealMelanoma website

Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.

15 Feb 2013

Stress and mental illness: an interview with Professor Akira Sawa

As a psychiatrist I am interested in how stress may play a role in the pathology of adult mental disorders. You may know that most of the major mental illnesses, such as schizophrenia, mood-disorder, substance abuse or even anxiety disorder, become prominent in early adulthood.

14 Feb 2013

As part of 'expansive' agenda, Obama offers support for 'modest' Medicare reforms

In last night's State of the Union address, President Barack Obama offered his take on how the U.S. budget could achieve "fiscal stability" through a mix of Medicare cuts and tax increases; however, he provided few details of what changes to Medicare he found acceptable.

14 Feb 2013

Military deployment increases risk of maternal depression in female service members

About 16,000 women on active duty in the U.S. military give birth each year. Most return to service after 6 weeks and can be deployed after 4 months. The potential for an increased risk of depression among new mothers who deploy and are exposed to combat experience is presented in a study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

13 Feb 2013

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma is a devastating disease. There are roughly 20-25,000 new cases per year in the United States and it is increasing for some reason.

12 Feb 2013

Brookdale fourth quarter total revenue increases 4.1% to $699.7 million

Brookdale Senior Living Inc. today reported financial and operating results for the fourth quarter and full year 2012.

11 Feb 2013

sFRP3 protein appears to be target of both antidepressant drugs and electroconvulsive therapy

Through a series of investigations in mice and humans, Johns Hopkins researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy.

11 Feb 2013

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Oncolytics Biotech Inc. today announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial in patients with squamous cell carcinoma of the lung (SCCLC) using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel (REO 021).

9 Feb 2013

Basis of antidepressant drugs and electroconvulsive therapy found

Through a series of investigations in mice and humans, Johns Hopkins researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. Results of their experiments explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.

7 Feb 2013

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

This work is the product of an extraordinary consortium called the Epilepsy Phenome/Genome project (EPGP). It is a consortium of 27 centres in the U.S. and internationally with several hundred physicians and staff who have worked together to enrol more than 4000 patients with epilepsy and their family members.

7 Feb 2013

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.

7 Feb 2013

CMS releases overdue final 'Sunshine Act' rule on payments to physicians

Under the Physician Payments Sunshine Act, financial relationships that drug and device makers have with doctors must be disclosed.

5 Feb 2013

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.

5 Feb 2013

Measles: an interview with Dr. Robert Perry, World Health Organization

Measles is a disease marked by fever, rash, and cold symptoms (red eyes, cough, runny nose) that results in a temporary suppression of the immune system and a drop in vitamin A levels.

4 Feb 2013